Compare Micron Technology, Inc. (MU) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Micron Technology, Inc. vs Oscar Health Inc — how do they compare? Micron Technology, Inc. trades at $1,029 (market cap $1.17T), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Micron Technology, Inc. is far larger — about 114.5× Oscar Health Inc's market cap, and Micron Technology, Inc. pays a 0.06% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Micron Technology, Inc. for 48 Days and Oscar Health Inc for 15 Days on average.
| MU | OSCR | |
|---|---|---|
Market Cap | $1.17T | $10.22B |
Volume | 29,425,906 | 4,123,394 |
Sector | Technology | Health |
52-Week High | $1.21K | $33.81 |
52-Week Low | $181.60 | $10.85 |
Typical Hold Time | 48 Days | 15 Days |
Enterprise Value | $1.13T | $6.57B |
Dividend Yield | 0.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Micron Technology (MU) trades at $1,035.84, down 4.79% on the day but maintains strong technical momentum with a bullish moving average signal. The company demonstrates exceptional fundamental strength with 63.8% net income margin and 91.77% ROE, supported by three consecutive quarterly earnings beats. Recent strategic customer agreements covering 35% of revenue through 2030 provide visibility into sustained AI-driven memory demand growth.
Outlook remains positive with analyst consensus target of $1,590 representing 53% upside potential. Key opportunities include AI memory market expansion and supply constraints through 2028, while risks center on cyclical industry dynamics and potential growth deceleration. The stock's current valuation at 13.94 P/E appears reasonable given growth trajectory.
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Micron Technology, Inc.
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
